{"id":"NCT02240030","sponsor":"Acorda Therapeutics","briefTitle":"Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes","officialTitle":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Investigating the Efficacy and Safety of CVT 301 (Levodopa Inhalation Powder) in Parkinson's Disease Patients With Motor Response Fluctuations (OFF Phenomena) (SPAN-PDâ„¢)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-11","primaryCompletion":"2016-12","completion":"2016-12","firstPosted":"2014-09-15","resultsPosted":"2018-04-17","lastUpdate":"2019-05-28"},"enrollment":351,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Idiopathic Parkinson's Disease"],"interventions":[{"type":"DRUG","name":"CVT-301 Low Dose","otherNames":["Inhaled levodopa"]},{"type":"DRUG","name":"CVT-301 High Dose","otherNames":["Inhaled levodopa"]},{"type":"OTHER","name":"Placebo","otherNames":["Inhalation-grade lactose"]}],"arms":[{"label":"CVT-301 Low Dose","type":"EXPERIMENTAL"},{"label":"CVT-301 High Dose","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This randomized, multicenter, placebo-controlled, double-blind study will evaluate the efficacy and safety of inhaled CVT 301 compared with placebo in PD patients experiencing motor response fluctuations (OFF phenomena) as an outpatient (i.e., at home) and in the clinic.\n\nPatients who successfully complete this study will be eligible to enroll into a 12 month treatment extension (CVT-301-004E) study.","primaryOutcome":{"measure":"Unified Parkinson's Disease Rating Scale (UPDRS) Part III","timeFrame":"30 minutes post-dose at week 12","effectByArm":[{"arm":"CVT-301 High Dose","deltaMin":-9.83,"sd":1.506},{"arm":"Placebo","deltaMin":-5.91,"sd":1.5}],"pValues":[]},"eligibility":{"minAge":"30 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":6},"locations":{"siteCount":74,"countries":["United States","Canada","Czechia","Poland","Spain"]},"refs":{"pmids":["30663606"],"seeAlso":["http://cvt301.acordatrials.com/en/patient/?src=clinicaltrialsgov004"]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":113},"commonTop":["Cough","Upper respiratory tract","Fall","Throat Irritation","Dyskinesia"]}}